Investing Ideas
/
U.K. Pharmaceuticals & Biotech High Return On Equity, Low Debt

U.K. Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

hVIVO

Market Cap: UK£111.6m

Operates as a pharmaceutical service and contract research company in the United Kingdom.

HVO

UK£0.16

10.8%

-39.7%